Trial intelligence / Profile preview

Role of Cerebral Blood Flow on Ventilatory Stability During Sleep

NCT03255408Phase 2Recruiting

Sponsor
University of Calgary
Start
Jan 2023
Primary completion
Dec 2027
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in obstructive sleep apnea (OSA) (4 arms), sponsored by University of Calgary. Primary endpoints: Changes in cerebral blood flow and ventilatory chemoreflexes at 18 months and Cerebral blood flow responses and ventilatory chemoreflexes during sleep at 18 months. Started Jan 2023; status: recruiting.

02

Conditions

obstructive sleep apnea (OSA)

Beyond the preview

Go deeper on NCT03255408.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03255408.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call